Cargando…

Distinct immunologic effects of different intravenous iron preparations on monocytes

BACKGROUND: Iron deficiency contributes to anaemia in patients with chronic kidney disease. I.v. iron is therefore widely used for anaemia treatment, although it may induce oxidative stress and activate monocytes. Different i.v. iron preparations are available, but interestingly their substance-spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fell, Lisa H., Zawada, Adam M., Rogacev, Kyrill S., Seiler, Sarah, Fliser, Danilo, Heine, Gunnar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967833/ https://www.ncbi.nlm.nih.gov/pubmed/24523357 http://dx.doi.org/10.1093/ndt/gft524

Ejemplares similares

Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells
por: Fell, Lisa H., et al.
Publicado: (2016)

Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease
por: Zawada, Adam M, et al.
Publicado: (2014)

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
por: Rogacev, Kyrill S., et al.
Publicado: (2016)

Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study
por: Emrich, Insa E., et al.
Publicado: (2021)

Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study
por: Emrich, Insa E, et al.
Publicado: (2021)

The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness
por: Weingärtner, Oliver, et al.
Publicado: (2010)

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients
por: Untersteller, Kathrin, et al.
Publicado: (2018)

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
por: Humalda, Jelmer K., et al.
Publicado: (2016)

Hypersensitivity to Intravenous Iron Preparations
por: Caimmi, Silvia, et al.
Publicado: (2022)

Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage
por: Brandenburg, Vincent, et al.
Publicado: (2020)

Iron Absorption Tests in Anæmia: The Use of Intravenous Iron Preparations
por: Crawley, Joan
Publicado: (1952)

The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report
por: Klingele, Matthias, et al.
Publicado: (2014)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
por: Emrich, I. E., et al.
Publicado: (2020)

Do two intravenous iron sucrose preparations have the same efficacy?
por: Rottembourg, Jacques, et al.
Publicado: (2011)

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk
por: Schaefer, Benedikt, et al.
Publicado: (2016)

The Kinetics of Circulating Monocyte Subsets and Monocyte-Platelet Aggregates in the Acute Phase of ST-Elevation Myocardial Infarction: Associations with 2-Year Cardiovascular Events
por: Zhou, Xin, et al.
Publicado: (2016)

Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways
por: Garbowski, Maciej W., et al.
Publicado: (2020)

Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA)
por: Neiser, Susann, et al.
Publicado: (2016)

Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review
por: Shah, Akshay, et al.
Publicado: (2019)

Influence of an intravenous fish oil emulsion on monocyte-endothelial interactions
por: Nohé, B, et al.
Publicado: (2001)

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
por: Hedenus, Michael, et al.
Publicado: (2014)

Ferrous iron content of intravenous iron formulations
por: Gupta, Ajay, et al.
Publicado: (2016)

Intravenous Iron Therapy with Saccharated Iron Oxide
por: Deshmukh, P. L.
Publicado: (1952)

Iron infusion and newer intravenous iron formulations
por: Aung, Tim, et al.
Publicado: (2021)

IMMUNOLOGICAL DISTINCTIONS OF ENCEPHALITIS AND POLIOMYELITIS
por: Amoss, Harold L.
Publicado: (1921)

Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
por: Lee, Thomas, et al.
Publicado: (2017)

The future of intravenous iron in nephrology
por: Coyne, Daniel W.
Publicado: (2011)

On the Preparation of an Improved Wine of Iron
por: Draper, H. N., et al.
Publicado: (1864)

Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival
por: Gupta, Ajay, et al.
Publicado: (2010)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Intravenous Iron Induced Severe Hypophosphatemia
por: Guo, Rong R, et al.
Publicado: (2021)

Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy
por: Jairam, A., et al.
Publicado: (2010)

Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
por: Elstrott, Benjamin K., et al.
Publicado: (2022)

Comparison of Oxidative Stress and Inflammation Induced by Different Intravenous Iron Sucrose Similar Preparations in a Rat Model
por: Toblli, Jorge Eduardo, et al.
Publicado: (2012)

Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation
por: Lofruthe, Niklas, et al.
Publicado: (2016)

Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
por: Yang, Xiuhua, et al.
Publicado: (2020)

Impact of Superparamagnetic Iron Oxide Nanoparticles on THP-1 Monocytes and Monocyte-Derived Macrophages
por: Polasky, Christina, et al.
Publicado: (2022)

Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study
por: Koch, Michael, et al.
Publicado: (2013)

Microbial Pattern Recognition Causes Distinct Functional Micro-RNA Signatures in Primary Human Monocytes
por: Häsler, Robert, et al.
Publicado: (2012)

Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD
por: Huang, Qiqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36gscrdcrrrhmdi11j25h0o2u9